STOCK TITAN

Neil H. Blumenthal (WRBY) files Form 144; 2,345-share 10b5-1 sale recorded

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Neil Harris Blumenthal filed a Form 144 on 04/17/2026 reporting securities to be sold through Morgan Stanley Smith Barney LLC. The filing lists 50,000 common shares tied to previously exercised options and restricted stock units. It also records a 10b5-1 sale of 2,345 shares on 04/16/2026 generating $56,466.66.

Positive

  • None.

Negative

  • None.
Filing date 04/17/2026 Form 144 filing date
Shares listed to be sold 50,000 shares Securities to be sold (previously exercised options and RSUs)
10b5-1 sale shares 2,345 shares Sale date <date>04/16/2026</date>
Proceeds reported $56,466.66 Proceeds from the 10b5-1 sale on <date>04/16/2026</date>
Aggregate amount listed $1,158,500.00 Amount shown in filing lines (as provided in excerpt)
Reference number 106,768,721 Numeric identifier included in the filing excerpt
10b5-1 regulatory
"10b5-1 Sales for NEIL HARRIS BLUMENTHAL 233 Spring Street"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Previously Exercised Options and Restricted Stock Units financial
"Previously Exercised Options and Restricted Stock Units | Issuer"
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the WRBY Form 144 filed on 04/17/2026 disclose?

It disclosed a filing by Neil Harris Blumenthal to sell securities through Morgan Stanley Smith Barney LLC. The form lists 50,000 common shares tied to previously exercised options and RSUs, and records a 10b5-1 sale of 2,345 shares on 04/16/2026.

How many shares did Neil Harris Blumenthal sell via 10b5-1 (WRBY)?

The filing shows a 10b5-1 sale of 2,345 shares on 04/16/2026. The transaction produced proceeds of $56,466.66 as reported on the form.

What volume is listed as available for sale in the WRBY Form 144?

The form lists 50,000 common shares under "Securities To Be Sold," associated with previously exercised options and restricted stock units dated 06/28/2017. Morgan Stanley Smith Barney LLC is shown as the broker.

Who is the broker-dealer handling the sale reported in the WRBY filing?

The broker-dealer listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY. The Form 144 includes that firm as the intermediary for the reported securities.

What proceeds were reported for the recent sale in the WRBY Form 144?

The filing records proceeds of $56,466.66 from the reported 10b5-1 sale of 2,345 common shares on 04/16/2026. The form shows cash treatment for the earlier securities dated 06/28/2017.